Printer Friendly

/C O R R E C T I O N -- Minntech Corporation/

 /C O R R E C T I O N -- Minntech Corporation/
 In MN017, Minntech Corporation Reports, moved yesterday, the tabular


material for Net earnings for the Three Months Ended 9/30/92 should read "$1,184" rather than "$1,884" as orginally transmitted. The corrected release follows:
 MINNTECH CORPORATION REPORTS SECOND QUARTER EARNINGS
 MINNEAPOLIS, Oct. 20 /PRNewswire/ -- Minntech Corporation (NASDAQ: MNTX) reported today net earnings of $1,184,000 or $.18 per common share for the second quarter ended Sept. 30, 1992, up 46 percent compared to net earnings of $811,000 or $.12 per common share for the second quarter last year. Revenues for the second quarter were $11,013,000, up 37 percent from revenues of $8,040,000 for the same period last year.
 For the six months ended Sept. 30, 1992, the company reported net earnings of $2,295,000 or $.35 per common share, up 44 percent compared to net earnings of $1,598,000 or $.24 per common share for the first six months one year ago. Revenues for the six-month period were $21,113,000, a 31 percent increase from revenues of $16,056,000 for the first six months last year.
 Dr. Louis C. Cosentino, president, reported, "We had significant sales growth in all of our businesses, led by our oxygenator and reprocessing products. Revenues and earnings for the quarter were in line with our forecast for the current fiscal year.
 "Net earnings for the second quarter were 10.8 percent of revenues, slightly below our 11 percent objective due to continued start-up costs in manufacturing our new high-flux dialyzer. We have scaled up production sharply and expect these start-up costs to subside in the third quarter. Overall, we are pleased with our results for the first six months and anticipate continued strong performance."
 Minntech Corporation is a leading medical device manufacturer with advanced technology in electronics, solutions, fibers and plastics. The company's core technologies are being applied to the business of dialysis, reprocessing/sterilants, cardiosurgery and water purification. Minntech Corporation's common stock is traded on the National Over-The- Counter market under the NASDAQ symbol: MNTX.
 MINNTECH CORPORATION
 Condensed Consolidated Statements of Operations
 (Unaudited)
 (In thousands except per share amounts)
 Three Months Ended Six Months Ended
 9/30/92 9/30/91 9/30/92 9/30/91
 Revenues
 Net sales - products $10,938 $8,040 $20,963 $16,056
 Contract revenues 75 -- 150 --
 Total revenues 11,013 8,040 21,113 16,056
 Operating costs and expenses
 Cost of product sales 6,284 4,514 11,978 9,055
 Research and development 636 523 1,194 1,066
 Selling, general
 and administrative 2,295 1,701 4,397 3,355
 Total operating costs
 and expenses 9,215 6,738 17,569 13,476
 Earnings from operations 1,798 1,302 3,544 2,580
 Income from settlement of
 litigation, net of expenses 99 -- 99 --
 Other income (expense), net (17) (34) (18) (82)
 Earnings before income taxes 1,880 1,268 3,625 2,498
 Income taxes 696 457 1,330 900
 Net earnings $1,184 $811 $2,295 $1,598
 Net earnings per share $.18 $.12 $.35 $.24
 Weighted average common and
 common equivalent shares 6,544 6,633 6,534 6,573
 -0- 10/21/92
 /CONTACT: Robert M. Rosner, executive vice president and treasurer of Minntech, 612-553-3300/
 (MNTX)


DS -- MN099C -- 2803 10/21/92 10:59 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 21, 1992
Words:569
Previous Article:ARVIN REPORTS RECORD THIRD QUARTER SALES
Next Article:VISA ATM SERVICES OPEN IN MOSCOW
Topics:


Related Articles
CONVERGENT SOLUTIONS RELEASES CS/ADS 6.4 DATABASE INDEPENDENT 4GL WITH INTERFACE TO INFORMIX
IBM AND MULTI SOFT SIGN SOFTWARE MARKETING AGREEMENT
DCA ANNOUNCES SELECT COMM SERVER WITH PC ROUTER SUPPORT
CompuServe, Golden CommPass Team Up To Reach OS-2 Market
Minntech Forms Strategic Alliance With Baxter Healthcare Corporation
Minntech's Subsidiary Minntech B.V. Receives ISO 9002 Quality Registration
Symantec Supports OS/2 Customers With New Antivirus Product
Minntech Corporation Announces Stock Purchase
Compuware Delivers Enhanced Enterprise Test Data Management Solution; Compuware File-AID/CS 3.0 Offers Rich Data-Management Functionality With...
Patients With HIV-Associated Wasting Gain More Weight With Concentrated Form of Megestrol Acetate, Study Shows.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters